Olabode Omotoso

Mr. Olabode Omotoso

University of Ibadan, Nigeria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2022 in Globalization and Health
Verified
Journal Article
Open access
PDF file
OOOlabode Omotoso
Olabode Omotoso
John Oluwafemi TeiboJohn Oluwafemi Teibo
John Oluwafemi Teibo
FAFestus Adebayo Atiba
Festus Adebayo Atiba
TOTolulope Oladimeji
Tolulope Oladimeji
AAAyomide Oluwadarasimi Adebesin
Ayomide Oluwadarasimi Adebesin
ABAhmed O. Babalghith
Ahmed O. Babalghith
This paper highlights the gap in the use of genomic data of Africans for global research efforts for disease cures. Genomic data represents an important tool used in disease research for understanding how diseases affect several populations and how these differences can be harnessed for the development of effective cures especially vaccines that have an impact at the genetic level e.g., RNA vaccines.This paper then provides a review of global genomic data status where three continents are reported to be the major contributor of genomic data to repositories used for disease research and the development of vaccines and medicines around the world.We reviewed the most recently published information about genetic data inclusiveness of populations, explaining how genomic data of Africans is lacking in global research efforts that cater towards the eradication of pandemics via the development of vaccines and other cures. We also discuss the implication of this non-inclusiveness for global disease burdens and indicate where changes need to be made in the last part of the paper.Lastly, the entire centers on some general policy recommendations to fully include African genomic data in such global genetic repositories. These recommendations can be implemented in African countries to improve genetic data collection, storage, and usage policies.

10 March 2023 in Heliyon
Verified
Journal Article
Open access
Abolaji Samson OlagunjuAbolaji Samson Olagunju
Abolaji Samson Olagunju
FAFoysal Ahammad
Foysal Ahammad
AAAbiola Adeyanju Alagbe
Abiola Adeyanju Alagbe
TOTitilayomi Ayomide Otenaike
Titilayomi Ayomide Otenaike
John Oluwafemi TeiboJohn Oluwafemi Teibo
John Oluwafemi Teibo
ETEnamul Kabir Talukder
Enamul Kabir Talukder
Mitochondrial dysfunction remains a pivotal mechanism in manifold neurodegenerative diseases. Mitochondrial homeostasis within the cell is an essential aspect of cell biology. Mitochondria, the power-generating organelle of the cell, have a dominant role in several processes associated with genomic integrity and cellular equilibrium. They are involved in maintaining optimal cell functioning and ensuring guidance against possible DNA damage, which could lead to mutations and the onset of diseases. Conversely, system perturbations, which could be due to environmental factors or senescence, induce changes in the physiological balance and result in mitochondrial function impairment. As a result, we present a general overview of the pathological pathways involved in Alzheimer's and Parkinson's diseases caused by changes in mitochondrial homeostasis. The focal point of this review is on mitochondrial dysfunction being a significant condition in the onset of neuronal disintegration. We explain the pathways associated with the dysfunction of the mitochondria, which are common among the most recurring neurodegenerative diseases, including Alzheimer's and Parkinson's disease. Are mitochondrial dysfunctions an early event in the progression of neuropathological processes? We discovered that mtDNA mutation is a major contributor to the metabolic pathology of most neurological disorders, causing changes in genes important for physiological homeostasis. As a result, genetic changes in presenilin, Amyloid-, ABAD, DJ-1, PINK-1, PARKIN, alpha-synuclein, and other important controlling genes occur. Therefore, we suggest possible therapeutic solutions.

27 June 2022 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
AAAyomide Oluwadarasimi Adebesin
Ayomide Oluwadarasimi Adebesin
AAAbigail Oluwakemi Ayodele
Abigail Oluwakemi Ayodele
OOOlabode Omotoso
Olabode Omotoso
PAPrecious Ayorinde Akinnusi
Precious Ayorinde Akinnusi
SOSamuel Olawale Olubode
Samuel Olawale Olubode
Background: β-catenin is an important unit of the Wnt/β-catenin signaling pathway, a conserved process involving several physiological activities, encompassing differentiation and cell proliferation, etc. The dysfunction or mutation in β-catenin causing the initiation and advancement of various neoplasm types, including colorectal cancer, breast cancer, etc., has been reported. Therefore, β-catenin is a therapeutic target. Hence, designing new inhibitors targeted against β-catenin will prevent cancerous cells’ involvement and eliminate the diseases. Studies showed that Vitis vinifera, a well-known grape species, contains different phytochemical substances, including aromatic acids, flavonoids, phenolic compounds, proanthocyanins, etc. V.vinifera exerts different anticancer properties such as apoptosis, cell proliferation, cell cycle arrest, and inhibition in cancerous cells. Structural bioinformatics methods, including molecular docking, molecular mechanics generalized Born surface area (MM/GBSA), absorption, distribution, metabolism, excretion studies (ADMET), and pharmacophore modeling approach, were used to determine the potential β-catenin inhibitors from V.vinifera bioactive compounds. Result: Cis-astringin, rutin, caftaric acid, trans-caftaric acid, procyanidin B3, cis-Miyabenol C, and ampelopsin H are shown to be suitable inhibitors against β-catenin due to their binding affinity and interaction with the amino acids residues at the binding sites of β-catenin compared to Food and Drug Administration (FDA) approved drugs leucovorin Calcium and Xeloda prescribed to cure colorectal cancer. Conclusions: This study suggests that V. vinifera could be a good plant source for compounds that might treat cancer by inhibiting the Wnt/β-catenin signaling pathway.

4 February 2021 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
OOOlabode Omotoso
Olabode Omotoso
ABAyoade D. Babalola
Ayoade D. Babalola
AMAmira Matareek
Amira Matareek
Background: Since outbreak in December 2019, the highly infectious and pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over a million deaths globally. With increasing burden, the novel coronavirus has posed a dire threat to public health, social interaction, and global economy. Mutations in the SARS-CoV-2 genome are moderately evolving which might have contributed to its genome variability, transmission, replication efficiency, and virulence in different regions of the world. Results: The present study elucidated the mutational landscape in the SARS-CoV-2 genome among the African populace, which may have contributed to the virulence, spread, and pathogenicity observed in the region. A total of 3045 SARS-CoV-2 complete protein sequences with the reference viral sequence (EPI_ISL_402124) were mined and analyzed. SARS-CoV-2 ORF1ab, spike, ORF3, ORF8, and nucleocapsid proteins were observed as mutational hotspots in the African population and may be of keen interest in understanding the viral host relationship, while there is conservation in the ORF6, ORF7a, ORF7b, ORF10, envelope, and membrane proteins. Conclusions: The accumulation of moderate mutations (though slowly), in the SARS-CoV-2 genome as seen in this present study, could be a promising strategy to develop antiviral drugs or vaccines. These antiviral interventions should target viral conserved domains and host cellular proteins and/or receptors involved in viral invasion and replication to avoid a new viral wave due to drug resistance and vaccine evasion.

9 December 2020 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
OOOlabode Omotoso
Olabode Omotoso
Background: The novel coronavirus disease (COVID-19) has claimed lots of lives, posing a dire threat to global health. It was predicted that the coronavirus outbreak in the African population would be very lethal and result to economic devastation owing to the prevalence of immune-compromised population, poverty, low lifespan, fragile health care systems, poor economy, and lifestyle factors. Accumulation of mutations gives virus selective advantage for host invasion and adaptation, higher transmissibility of more virulent strains, and drug resistance. The present study determined the severe acute respiratory syndrome-2 (SARS-CoV-2) genomic variability and the contributory factors to the low COVID-19 fatality in Africa. To assess the SARS-CoV-2 mutational landscape, 924 viral sequences from the Africa region with their sociobiological characteristics mined from the Global Initiative on Sharing All Influenza Data (GISAID) database were analyzed. Results: Mutational analysis of the SARS-CoV-2 sequences revealed highly recurrent mutations in the SARS-CoV-2 spike glycoprotein D614G (97.2%), concurrent R203K, and G204R (65.2%) in the nucleocapsid phosphoprotein, and P4715L (97.2%) in the RNA-dependent RNA polymerase flagging these regions as SARS-CoV-2 mutational hotspots in the African population. COVID-19 is more severe in older people (> 65 years); Africa has a low percentage of people within this age group (4.36%). The average age of the infected patients observed in this study is 46 years with only 47 infected patients (5.1%) above 65 years in Africa in comparison to 13.12% in countries in other continents with the highest prevalence of COVID-19. Conclusions: Africa’s young generation, the late incidence of the disease, and adherence to public health guidelines are important indicators that may have contributed to the observed low COVID-19 deaths in Africa. However, with the easing of lockdown and regulatory policies, daily increasing incidence in most countries, and low testing and sequencing rate, the epidemiology and the true impact of the pandemic in Africa remain to be unraveled.

1 September 2021 in SciMedicine Journal
Verified
Journal Article
Closed access
PDF file
OOOlabode Omotoso
Olabode Omotoso
GMGhadier Matariek
Ghadier Matariek
EOElizabeth F. Omotoso
Elizabeth F. Omotoso
AMAmira Matareek
Amira Matareek
GAGhada M. Abdul-Rafee
Ghada M. Abdul-Rafee
NCNabanita Chutia
Nabanita Chutia
The burden of breast and cervical cancer is increasing exponentially, especially among women in low- and mid-income countries. Early detection, hinged on screening uptake is a key to higher survival rate and managing cancer outcome. The present study assessed Nigerians and Egyptians’ knowledge of breast self-examination (BSE) and breast and cervical cancer screening. A cross-sectional questionnaire was utilized to obtain 1,006 respondents via a convenient sampling method. The mean age of respondents was 30.43 ± 6.69. About one-third of participants had good knowledge (> 66%) of breast cancer screening (42%), cervical cancer screening (44%) and BSE practice (36%). Age range (26–40 years), educational level (tertiary), and marital status were demographic data that influenced knowledge level. The screening uptake among the studied population is very poor as only (11%) had ever been screened and only (2.2%) ever vaccinated. The major reasons for poor screening uptake were “no awareness of where to be screened” and “no symptoms”. Assessing the knowledge and uptake level of African women through studies like this is crucial in identifying the loopholes in the fight against cancer. More efforts are required for promoting the utilization of cancer screening services, HPV vaccination, and BSE practice among African women. Doi: 10.28991/SciMedJ-2021-0303-3 Full Text: PDF